nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Methylprednisolone—psoriatic arthritis	0.154	0.279	CbGbCtD
Vecuronium—ABCB1—Betamethasone—psoriatic arthritis	0.1	0.182	CbGbCtD
Vecuronium—ABCB1—Prednisolone—psoriatic arthritis	0.099	0.179	CbGbCtD
Vecuronium—ABCB1—Prednisone—psoriatic arthritis	0.0935	0.169	CbGbCtD
Vecuronium—ABCB1—Dexamethasone—psoriatic arthritis	0.0584	0.106	CbGbCtD
Vecuronium—ABCB1—Methotrexate—psoriatic arthritis	0.0469	0.0849	CbGbCtD
Vecuronium—Steroid myopathy—Prednisolone—psoriatic arthritis	0.0359	0.0801	CcSEcCtD
Vecuronium—Steroid myopathy—Triamcinolone—psoriatic arthritis	0.033	0.0737	CcSEcCtD
Vecuronium—Steroid myopathy—Methylprednisolone—psoriatic arthritis	0.0329	0.0735	CcSEcCtD
Vecuronium—Steroid myopathy—Dexamethasone—psoriatic arthritis	0.0299	0.0668	CcSEcCtD
Vecuronium—Steroid myopathy—Betamethasone—psoriatic arthritis	0.0299	0.0668	CcSEcCtD
Vecuronium—Steroid myopathy—Prednisone—psoriatic arthritis	0.0261	0.0582	CcSEcCtD
Vecuronium—Muscle atrophy—Methylprednisolone—psoriatic arthritis	0.0161	0.036	CcSEcCtD
Vecuronium—Muscle atrophy—Dexamethasone—psoriatic arthritis	0.0146	0.0327	CcSEcCtD
Vecuronium—Muscle atrophy—Betamethasone—psoriatic arthritis	0.0146	0.0327	CcSEcCtD
Vecuronium—Muscle atrophy—Prednisone—psoriatic arthritis	0.0127	0.0285	CcSEcCtD
Vecuronium—Myopathy—Prednisolone—psoriatic arthritis	0.0059	0.0132	CcSEcCtD
Vecuronium—Myopathy—Triamcinolone—psoriatic arthritis	0.00542	0.0121	CcSEcCtD
Vecuronium—Myopathy—Methylprednisolone—psoriatic arthritis	0.00541	0.0121	CcSEcCtD
Vecuronium—Angioedema—Auranofin—psoriatic arthritis	0.00518	0.0116	CcSEcCtD
Vecuronium—Myopathy—Dexamethasone—psoriatic arthritis	0.00492	0.011	CcSEcCtD
Vecuronium—Myopathy—Betamethasone—psoriatic arthritis	0.00492	0.011	CcSEcCtD
Vecuronium—Rash erythematous—Betamethasone—psoriatic arthritis	0.0045	0.0101	CcSEcCtD
Vecuronium—Rash erythematous—Dexamethasone—psoriatic arthritis	0.0045	0.0101	CcSEcCtD
Vecuronium—Myopathy—Prednisone—psoriatic arthritis	0.00428	0.00957	CcSEcCtD
Vecuronium—Urticaria—Auranofin—psoriatic arthritis	0.00367	0.00821	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—psoriatic arthritis	0.00361	0.00807	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.0031	0.00693	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—psoriatic arthritis	0.00296	0.00662	CcSEcCtD
Vecuronium—Rash—Auranofin—psoriatic arthritis	0.00292	0.00651	CcSEcCtD
Vecuronium—Dermatitis—Auranofin—psoriatic arthritis	0.00291	0.00651	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00285	0.00637	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00284	0.00635	CcSEcCtD
Vecuronium—Muscular weakness—Prednisolone—psoriatic arthritis	0.00265	0.00591	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00259	0.00578	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00259	0.00578	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—psoriatic arthritis	0.00256	0.00571	CcSEcCtD
Vecuronium—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00243	0.00544	CcSEcCtD
Vecuronium—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00243	0.00542	CcSEcCtD
Vecuronium—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00234	0.00523	CcSEcCtD
Vecuronium—Muscular weakness—Betamethasone—psoriatic arthritis	0.00221	0.00493	CcSEcCtD
Vecuronium—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00221	0.00493	CcSEcCtD
Vecuronium—Face oedema—Prednisone—psoriatic arthritis	0.00211	0.0047	CcSEcCtD
Vecuronium—Muscular weakness—Prednisone—psoriatic arthritis	0.00192	0.0043	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00188	0.00421	CcSEcCtD
Vecuronium—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00187	0.00418	CcSEcCtD
Vecuronium—Erythema—Prednisolone—psoriatic arthritis	0.00181	0.00404	CcSEcCtD
Vecuronium—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00177	0.00395	CcSEcCtD
Vecuronium—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00173	0.00386	CcSEcCtD
Vecuronium—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00172	0.00384	CcSEcCtD
Vecuronium—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00172	0.00383	CcSEcCtD
Vecuronium—Erythema—Triamcinolone—psoriatic arthritis	0.00166	0.00371	CcSEcCtD
Vecuronium—Erythema—Methylprednisolone—psoriatic arthritis	0.00166	0.0037	CcSEcCtD
Vecuronium—Angioedema—Prednisolone—psoriatic arthritis	0.00165	0.00369	CcSEcCtD
Vecuronium—Angiopathy—Betamethasone—psoriatic arthritis	0.00157	0.00351	CcSEcCtD
Vecuronium—Angiopathy—Dexamethasone—psoriatic arthritis	0.00157	0.00351	CcSEcCtD
Vecuronium—Angioedema—Triamcinolone—psoriatic arthritis	0.00152	0.00339	CcSEcCtD
Vecuronium—Angioedema—Methylprednisolone—psoriatic arthritis	0.00152	0.00338	CcSEcCtD
Vecuronium—Erythema—Betamethasone—psoriatic arthritis	0.00151	0.00337	CcSEcCtD
Vecuronium—Erythema—Dexamethasone—psoriatic arthritis	0.00151	0.00337	CcSEcCtD
Vecuronium—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00148	0.00331	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00147	0.00329	CcSEcCtD
Vecuronium—Shock—Prednisolone—psoriatic arthritis	0.00145	0.00324	CcSEcCtD
Vecuronium—Tachycardia—Prednisolone—psoriatic arthritis	0.00144	0.00322	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.0014	0.00313	CcSEcCtD
Vecuronium—Flushing—Prednisone—psoriatic arthritis	0.0014	0.00313	CcSEcCtD
Vecuronium—Angioedema—Betamethasone—psoriatic arthritis	0.00138	0.00308	CcSEcCtD
Vecuronium—Angioedema—Dexamethasone—psoriatic arthritis	0.00138	0.00308	CcSEcCtD
Vecuronium—Angiopathy—Prednisone—psoriatic arthritis	0.00137	0.00306	CcSEcCtD
Vecuronium—Immune system disorder—Prednisone—psoriatic arthritis	0.00136	0.00304	CcSEcCtD
Vecuronium—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00136	0.00303	CcSEcCtD
Vecuronium—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00135	0.00302	CcSEcCtD
Vecuronium—Shock—Triamcinolone—psoriatic arthritis	0.00133	0.00298	CcSEcCtD
Vecuronium—Shock—Methylprednisolone—psoriatic arthritis	0.00133	0.00297	CcSEcCtD
Vecuronium—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00133	0.00296	CcSEcCtD
Vecuronium—Tachycardia—Triamcinolone—psoriatic arthritis	0.00132	0.00296	CcSEcCtD
Vecuronium—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00132	0.00295	CcSEcCtD
Vecuronium—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00131	0.00294	CcSEcCtD
Vecuronium—Erythema—Prednisone—psoriatic arthritis	0.00131	0.00293	CcSEcCtD
Vecuronium—Hypotension—Methylprednisolone—psoriatic arthritis	0.00126	0.00282	CcSEcCtD
Vecuronium—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00123	0.00275	CcSEcCtD
Vecuronium—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00123	0.00275	CcSEcCtD
Vecuronium—Shock—Dexamethasone—psoriatic arthritis	0.00121	0.0027	CcSEcCtD
Vecuronium—Shock—Betamethasone—psoriatic arthritis	0.00121	0.0027	CcSEcCtD
Vecuronium—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00121	0.0027	CcSEcCtD
Vecuronium—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00121	0.0027	CcSEcCtD
Vecuronium—Tachycardia—Dexamethasone—psoriatic arthritis	0.0012	0.00268	CcSEcCtD
Vecuronium—Tachycardia—Betamethasone—psoriatic arthritis	0.0012	0.00268	CcSEcCtD
Vecuronium—Angioedema—Prednisone—psoriatic arthritis	0.0012	0.00268	CcSEcCtD
Vecuronium—Urticaria—Prednisolone—psoriatic arthritis	0.00117	0.00262	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00117	0.00261	CcSEcCtD
Vecuronium—Hypotension—Betamethasone—psoriatic arthritis	0.00115	0.00257	CcSEcCtD
Vecuronium—Hypotension—Dexamethasone—psoriatic arthritis	0.00115	0.00257	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—psoriatic arthritis	0.00114	0.00256	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—psoriatic arthritis	0.00114	0.00254	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00114	0.00254	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00111	0.00248	CcSEcCtD
Vecuronium—Erythema—Methotrexate—psoriatic arthritis	0.0011	0.00245	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00109	0.00243	CcSEcCtD
Vecuronium—Urticaria—Triamcinolone—psoriatic arthritis	0.00108	0.00241	CcSEcCtD
Vecuronium—Urticaria—Methylprednisolone—psoriatic arthritis	0.00108	0.0024	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00107	0.00239	CcSEcCtD
Vecuronium—Shock—Prednisone—psoriatic arthritis	0.00105	0.00236	CcSEcCtD
Vecuronium—Nervous system disorder—Prednisone—psoriatic arthritis	0.00105	0.00235	CcSEcCtD
Vecuronium—Tachycardia—Prednisone—psoriatic arthritis	0.00105	0.00234	CcSEcCtD
Vecuronium—Skin disorder—Prednisone—psoriatic arthritis	0.00104	0.00233	CcSEcCtD
Vecuronium—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000999	0.00223	CcSEcCtD
Vecuronium—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000997	0.00223	CcSEcCtD
Vecuronium—Urticaria—Dexamethasone—psoriatic arthritis	0.000978	0.00218	CcSEcCtD
Vecuronium—Urticaria—Betamethasone—psoriatic arthritis	0.000978	0.00218	CcSEcCtD
Vecuronium—Rash—Prednisolone—psoriatic arthritis	0.00093	0.00208	CcSEcCtD
Vecuronium—Dermatitis—Prednisolone—psoriatic arthritis	0.000929	0.00208	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000928	0.00207	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000896	0.002	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000878	0.00196	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—psoriatic arthritis	0.00087	0.00194	CcSEcCtD
Vecuronium—Rash—Triamcinolone—psoriatic arthritis	0.000855	0.00191	CcSEcCtD
Vecuronium—Dermatitis—Triamcinolone—psoriatic arthritis	0.000854	0.00191	CcSEcCtD
Vecuronium—Rash—Methylprednisolone—psoriatic arthritis	0.000853	0.00191	CcSEcCtD
Vecuronium—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000853	0.0019	CcSEcCtD
Vecuronium—Urticaria—Prednisone—psoriatic arthritis	0.000851	0.0019	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—psoriatic arthritis	0.000837	0.00187	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisone—psoriatic arthritis	0.00079	0.00176	CcSEcCtD
Vecuronium—Rash—Betamethasone—psoriatic arthritis	0.000776	0.00173	CcSEcCtD
Vecuronium—Rash—Dexamethasone—psoriatic arthritis	0.000776	0.00173	CcSEcCtD
Vecuronium—Dermatitis—Dexamethasone—psoriatic arthritis	0.000775	0.00173	CcSEcCtD
Vecuronium—Dermatitis—Betamethasone—psoriatic arthritis	0.000775	0.00173	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—psoriatic arthritis	0.000712	0.00159	CcSEcCtD
Vecuronium—Rash—Prednisone—psoriatic arthritis	0.000676	0.00151	CcSEcCtD
Vecuronium—Dermatitis—Prednisone—psoriatic arthritis	0.000675	0.00151	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00066	0.00147	CcSEcCtD
Vecuronium—Rash—Methotrexate—psoriatic arthritis	0.000565	0.00126	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—psoriatic arthritis	0.000564	0.00126	CcSEcCtD
